Maxalt (rizatriptan) is a fast-acting triptan used for the acute treatment of migraine attacks, with or without aura, in adults and certain pediatric patients. Available as conventional tablets and orally disintegrating tablets (ODT), it targets migraine pathways to reduce headache pain and associated symptoms such as nausea, light sensitivity, and sound sensitivity. Maxalt is not a preventive medicine and should be taken at the first sign of a migraine. When used as directed, many patients experience meaningful relief within 2 hours. Talk with a healthcare professional to ensure Maxalt is appropriate for your medical history and other medications.
Maxalt (generic name: rizatriptan) is a prescription triptan indicated for the acute treatment of migraine attacks, with or without aura. It is designed to treat a migraine that has already started; it is not meant to prevent headaches or reduce the frequency of attacks. Maxalt addresses hallmark migraine symptoms, including moderate to severe head pain, nausea, photophobia (light sensitivity), and phonophobia (sound sensitivity).
Clinically, Maxalt is most effective when taken early in an attack. Some people report relief within 30–60 minutes, with more substantial improvement by 2 hours. It can be used by adults and certain pediatric patients (6–17 years) when prescribed appropriately. It should not be used for other headache types like cluster headaches, and it is not appropriate for people with specific cardiovascular conditions.
Rizatriptan is a selective 5‑HT1B/1D receptor agonist. By stimulating serotonin receptors in cranial blood vessels and the trigeminal system, Maxalt helps constrict dilated intracranial arteries and reduces the release of pro‑inflammatory neuropeptides. This dual action decreases migraine pain transmission and relieves associated symptoms. Its targeted mechanism is why triptans like Maxalt are recommended first-line for many moderate to severe migraine attacks, especially when NSAIDs alone are insufficient.
Adults: The typical starting dose is 5 mg or 10 mg taken at the first sign of migraine. If the headache returns or only partially improves, a second dose may be taken at least 2 hours after the first. Do not exceed 30 mg in a 24‑hour period. Choose the lowest effective dose that controls your symptoms; some patients need only 5 mg, while others respond better to 10 mg.
Pediatric patients (6–17 years): Dosing may be weight-based. Many prescribers use 5 mg for lower body weight and 10 mg for higher body weight. In children and adolescents, a repeat dose within 24 hours is often not recommended due to limited safety data—follow your clinician’s specific instructions for your child.
With propranolol: Propranolol can significantly increase rizatriptan levels. If you take propranolol, the recommended Maxalt dose is 5 mg, with a maximum of 15 mg in 24 hours. Ask your prescriber about timing, as spacing doses may be advised.
Administration tips: Maxalt comes as a standard tablet and an orally disintegrating tablet (ODT). ODTs can be placed on the tongue to dissolve without water—useful for nausea. Maxalt may be taken with or without food, but a high-fat meal might delay onset slightly. Avoid taking more than 10 triptan-treated days per month, when possible, to reduce the risk of medication overuse headache.
Cardiovascular risk: Triptans can cause vasoconstriction of coronary arteries. Maxalt should be used with caution in patients with cardiovascular risk factors (e.g., diabetes, smoking, hypertension, hyperlipidemia, family history of early heart disease), especially men over 40 and postmenopausal women. Some may need a cardiovascular evaluation before first use. Seek emergency care if you experience chest pain, severe shortness of breath, or symptoms suggestive of a heart attack or stroke.
Serotonin syndrome: Combining rizatriptan with SSRIs, SNRIs, MAO inhibitors, or other serotonergic agents can rarely trigger serotonin syndrome. Warning signs include agitation, confusion, rapid heart rate, sweating, muscle rigidity, and fever. If these occur, get urgent medical help. Do not combine Maxalt within 24 hours of another triptan or ergotamine product.
Other considerations: Maxalt is not for hemiplegic or basilar/brainstem migraines. Use cautiously in patients with significant hepatic impairment; dose adjustments may be necessary. Severe renal impairment may also require caution. Drowsiness and dizziness can occur—do not drive or operate machinery until you know how Maxalt affects you. For pregnancy and breastfeeding, discuss risks and benefits with your clinician; available data are limited, and treatment should be individualized.
Do not take Maxalt if you have: coronary artery disease or vasospastic angina (Prinzmetal), a history of stroke or TIA, peripheral vascular disease, ischemic bowel disease, uncontrolled hypertension, hemiplegic or basilar migraine, or a known hypersensitivity to rizatriptan. These conditions increase the risk of serious cardiovascular or cerebrovascular events with triptan use.
Maxalt is contraindicated with MAO‑A inhibitors (or within 2 weeks of stopping an MAOI) due to markedly increased rizatriptan levels. It should also not be used within 24 hours of another triptan, ergotamine, dihydroergotamine (DHE), or ergot‑type medication.
Common, usually transient effects include dizziness, fatigue, somnolence (sleepiness), dry mouth, flushing, warmth or tingling (paresthesias), nausea, and neck or jaw discomfort. Some patients notice tightness or pressure sensations in the chest or throat that are not related to heart disease; however, any severe or persistent chest pain requires urgent evaluation to rule out cardiac causes.
Less common but serious events can include myocardial ischemia or infarction, arrhythmias, stroke, transient ischemic attack, severe increases in blood pressure, and serotonin syndrome (especially with serotonergic drug combinations). Anaphylaxis and other allergic reactions are rare but possible. Stop Maxalt and seek medical care if you experience hives, swelling of the face or throat, wheezing, or difficulty breathing.
Overuse of acute migraine medicines (including triptans) can lead to medication overuse headache. If you find yourself needing Maxalt more than 10 days per month, consult your clinician about preventive strategies and alternative acute therapies.
MAO‑A inhibitors: Contraindicated. Concomitant use dramatically increases rizatriptan exposure and risk of adverse effects. Do not use Maxalt if you are currently on an MAOI or have taken one in the last 14 days.
Propranolol: Increases plasma levels of rizatriptan. Limit Maxalt to 5 mg per dose, not to exceed 15 mg in 24 hours. Other beta‑blockers generally have less impact, but discuss all heart medications with your prescriber.
Other serotonergic agents: Use caution with SSRIs, SNRIs, TCAs, tramadol, linezolid, methylene blue, St. John’s wort, and triptans or ergot derivatives. Combining serotonergic drugs can increase the risk of serotonin syndrome. Avoid using Maxalt within 24 hours of another triptan or any ergotamine‑containing product. Always provide your pharmacist a complete list of prescription drugs, OTC medicines (e.g., decongestants), and supplements.
Maxalt is used as needed for an active migraine, so there is no “missed dose” on a schedule. Take one dose at the onset of headache. If the migraine improves but then returns, you may take a second dose at least 2 hours after the first (adults), staying within daily maximums. Do not double a dose to make up for a missed opportunity. If headaches are frequent or you often need a second dose, ask your clinician about optimizing your treatment plan.
Signs of overdose may include severe dizziness, fainting, rapid or irregular heartbeat, chest pain, vomiting, pronounced drowsiness, or high blood pressure. If you suspect an overdose, call your local emergency number or Poison Control (1‑800‑222‑1222 in the U.S.) immediately. There is no specific antidote; management is supportive. Hemodialysis is unlikely to meaningfully remove rizatriptan. Bring the medication bottle or blister pack to assist healthcare professionals.
Store Maxalt tablets at room temperature (68–77°F or 20–25°C) in a dry place away from excess heat and moisture. Keep ODTs in their original blister packaging until use to protect from humidity. Do not use tablets that are discolored, cracked, or past the expiration date. Keep out of reach of children and pets, and dispose of unused or expired medication according to your pharmacist’s guidance or local take‑back programs.
In the United States, Maxalt (rizatriptan) is a prescription‑only medicine. Federal and state laws require that a licensed clinician determine whether Maxalt is appropriate for you based on your medical history, migraine diagnosis, and potential contraindications. Buying prescription drugs from unverified sources or without proper clinical evaluation can be unsafe and unlawful.
HealthSouth Rehabilitation Hospital of Manati supports a legal and structured path to therapy by facilitating access to licensed pharmacists and, where available, clinician evaluation through compliant telehealth services. This ensures that any dispensing of Maxalt follows applicable regulations, includes necessary medical review, and provides counseling on safe use, dosing, and interactions. If you do not currently have a prescriber, HealthSouth Rehabilitation Hospital of Manati can help connect you with a qualified clinician to assess your migraines and, if appropriate, issue a valid prescription.
When you choose HealthSouth Rehabilitation Hospital of Manati, you benefit from transparent pricing, guidance on insurance or cash‑pay options, and shipment from legitimate, U.S.‑based pharmacy channels. Always avoid “no‑prescription” offers from unverified sellers. For safe, compliant access to Maxalt, start with a professional evaluation and pharmacist support so your treatment is both effective and legally sound.
Maxalt (rizatriptan) is a triptan used for acute migraine attacks. It activates 5‑HT1B/1D serotonin receptors to constrict dilated cranial blood vessels and block pain-signaling neuropeptides like CGRP, reducing inflammation and pain when taken at the first sign of headache.
It treats acute migraine with or without aura in adults and in certain children and teens. It does not prevent migraines, and it isn’t for tension headaches, cluster headaches, or hemiplegic or brainstem (basilar-type) migraine.
Avoid it if you have coronary artery disease, history of heart attack or stroke/TIA, peripheral vascular disease, uncontrolled hypertension, severe liver disease, hemiplegic or basilar migraine, or allergy to rizatriptan. Do not use it within 24 hours of another triptan or an ergot drug, or if you take an MAO‑A inhibitor or have taken one in the past 2 weeks.
Many people start to feel relief within 30–60 minutes, with peak benefit around 1–2 hours. Its effect can wear off as the drug clears in a few hours, and some attacks may recur later in the day.
Swallow the standard tablet with water as soon as the headache starts. The ODT dissolves on the tongue without water, which can be convenient if you’re nauseated; it provides similar absorption and effectiveness to the regular tablet.
If your symptoms return or don’t fully resolve, a second dose is often allowed at least 2 hours after the first, staying within the maximum daily amount on your prescription. To avoid medication-overuse headache, try not to use triptans more than about 9–10 days per month.
Tingling, dizziness, sleepiness, fatigue, dry mouth, flushing, and tightness or pressure in the chest, throat, neck, or jaw can occur and usually fade. Seek urgent care for severe chest pain, shortness of breath, one-sided weakness, sudden confusion, or signs of serotonin syndrome such as agitation, sweating, tremor, or fast heartbeat.
Caution is warranted with SSRIs, SNRIs, TCAs, and certain other serotonergic drugs due to a rare risk of serotonin syndrome; most people can use them together with monitoring. Do not use Maxalt with MAO‑A inhibitors.
Propranolol can raise rizatriptan levels; your prescriber may use a lower rizatriptan dose if you take propranolol. Avoid using Maxalt within 24 hours of ergot migraine medicines, and tell your clinician about all cardiac drugs you use.
Data in pregnancy are limited; use only if the expected benefit outweighs potential risks after discussing options with your clinician. Small amounts may pass into breast milk; many clinicians advise timing doses after a feed and monitoring the infant for sedation or poor feeding.
Rizatriptan is approved for some children and adolescents aged 6–17 with migraine, using age- and weight-appropriate dosing. A pediatric clinician should guide its use and frequency.
Take it early in the attack, at the dose your clinician prescribed. If relief is inadequate, your clinician may adjust timing/dose, try a different triptan or a non-triptan acute option (like a gepant or ditan), or discuss preventive therapy if attacks are frequent.
If you feel dizzy, drowsy, or “foggy,” wait until you feel fully alert before driving or operating machinery. Effects vary by person and by attack.
Keep tablets in a cool, dry place. For ODT, open the blister with dry hands only when ready to use, as moisture can damage the tablet.
Many clinicians pair a triptan with an NSAID such as ibuprofen or naproxen for added effect, and anti-nausea agents can be used when needed; ask your prescriber what’s right for you. Avoid combining with other triptans or ergot drugs within 24 hours.
Yes, but triptans tend to work best when taken at headache onset rather than during aura alone. If your attacks are predictable, discuss timing strategies with your clinician.
Limit triptan use to the fewest days needed; using them on 10 or more days per month can trigger medication-overuse headache. If you need frequent treatment, ask about prevention.
Alcohol can trigger or worsen migraines and may increase dizziness or drowsiness. It’s best to avoid alcohol around the time of an attack and while using Maxalt.
Share your full headache history; heart, blood vessel, liver, or kidney issues; pregnancy or breastfeeding status; and all medicines and supplements, especially antidepressants, propranolol, MAOIs, and migraine drugs.
Sumatriptan injection is the fastest triptan overall, often relieving pain within 10–15 minutes. For oral forms, many patients find rizatriptan and sumatriptan similarly fast, with some studies suggesting a slight edge for rizatriptan in early pain relief.
Head-to-head analyses often place eletriptan 40 mg and rizatriptan 10 mg among the most effective oral triptans for 2‑hour pain freedom. Eletriptan can have more interactions with strong CYP3A4 inhibitors, so choice depends on your health profile and other meds.
Zolmitriptan has a nasal spray option that can bypass the gut and work when swallowing is hard. Maxalt-MLT (ODT) is convenient without water but still relies on GI absorption.
Frovatriptan has a very long half-life and tends to have lower recurrence for long or menstrual-related attacks but a slower onset. Maxalt usually acts faster but may wear off sooner for some people.
Naratriptan has slower onset and is often well tolerated with fewer side effects. Maxalt tends to act quicker and may provide stronger early relief.
Both are well tolerated; almotriptan generally has few clinically significant interactions. Maxalt requires dose considerations with propranolol and should not be used with MAO‑A inhibitors.
Sumatriptan nasal spray can act faster than oral tablets and is helpful when nausea or vomiting is prominent. Maxalt ODT is convenient but typically not as fast as a nasal or injectable route.
Many patients respond to both; evidence suggests rizatriptan 10 mg may slightly outperform sumatriptan 50 mg for 2‑hour pain freedom, but individual response varies. Trying more than one triptan is common to find the best fit.
Eletriptan is not recommended with potent CYP3A4 inhibitors (like certain antifungals, macrolides, or protease inhibitors). Maxalt is primarily metabolized by MAO‑A and interacts notably with propranolol and MAOIs.
Yes, but never take two triptans within the same 24‑hour period or combine a triptan with an ergot drug in that window. You can trial a different triptan for a future attack under your clinician’s guidance.
For short-term prevention around menses, longer-acting triptans like frovatriptan or naratriptan are often used; Maxalt is for acute treatment, not prevention. Any of them can be used as an acute rescue depending on your response.
Longer-acting agents like frovatriptan and naratriptan usually have lower recurrence but slower onset. Faster agents like rizatriptan often provide quicker relief with a higher chance of needing a second dose.
Most triptans are available as generics; sumatriptan is often the least expensive, while rizatriptan is also widely affordable. Insurance formularies vary, so coverage and copays can differ.
The propranolol interaction is most clinically relevant with rizatriptan and can require a lower rizatriptan dose. Other triptans are less affected by propranolol, though each drug has its own interaction profile.
Guidelines often suggest starting with an oral triptan that balances speed, tolerability, and cost, such as sumatriptan, rizatriptan, or almotriptan. If the first choice isn’t ideal, switching within the class is common and can make a big difference.